Featured Research

from universities, journals, and other organizations

New insights into cancer treatment

Date:
March 15, 2011
Source:
VIB (the Flanders Institute for Biotechnology)
Summary:
A researcher strongly argues against the use of Cop1-inhibitory drugs.

Jean-Christophe Marine (VIB, K.U.Leuven) strongly argues against the use of Cop1-inhibitory drugs. The protein Cop1 has -for a long time -- been seen as an attractive drug target for cancer. But Jean-Christophe Marine found out that Cop1 acts as a tumor suppressor, and thus inhibits tumor formation. His new data will have direct implications for the development of cancer drug targets.

Tumorigenesis: loss of control

Tumors form when control over the cell division is lost; a process that could be compared to losing control over the speed of your car. Two main players are involved; oncogenes which could be compared to the gas pedal of the car. A defective oncogene would be analogous to a gas pedal that is stuck in the 'on' position. In such a situation the tumor suppressor genes function as the brakes of the car -- they keep the cell from dividing even in response to oncogene activation. If the brakes fail, the car goes out of control; similarly, when something goes wrong with the tumor suppressor genes, cell division gets out of control.

Cop1: brake or gas pedal?

Although Cop1 has been implicated in tumorigenesis, its precise role has remained a conundrum. Biochemical studies had shown that Cop1 promotes the degradation of target proteins. These studies, however, have yielded conflicting results leaving an open question as to whether Cop1 degrade tumor suppressors or oncogenes.

Several studies have indeed indicated that Cop1 favors tumorigenesis by inactivating one of the key tumor suppressors, p53. Accordingly, Cop1 overexpression was reported in breast and ovarian adenocarcinomas. Cop1 was therefore considered to be an oncogene and an attractive drug target for cancer therapy.

Solving the Cop1 puzzle has major implications for cancer drug development

Jean-Christophe Marine and his team now show that it is quite the opposite, namely that Cop1 functions as a tumor suppressor. Using an innovative mouse genetic engineering approach the VIB scientists generated Cop1-deficient mice. They show that these mice are highly tumor prone. They also show that Cop1 regulates the stability of the oncogene c-Jun and that deficiency of Cop1 stimulates cell proliferation of mouse and human cancer cells. In keeping with these data, they provide evidence that Cop1 expression is lost in various human cancers. Crucially for cancer therapy, they could find no evidence for the previously suggested role of Cop1 in the regulation of the tumor suppressor p53.

Jean-Christophe Marine said, 'Our findings strongly argue against the use of Cop1-inhibitory drugs in cancer therapy.'


Story Source:

The above story is based on materials provided by VIB (the Flanders Institute for Biotechnology). Note: Materials may be edited for content and length.


Journal Reference:

  1. Domenico Migliorini, Sven Bogaerts, Dieter Defever, Rajesh Vyas, Geertrui Denecker, Enrico Radaelli, Aleksandra Zwolinska, Vanessa Depaepe, Tino Hochepied, William C. Skarnes, Jean-Christophe Marine. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice. Journal of Clinical Investigation, 2011; DOI: 10.1172/JCI45784

Cite This Page:

VIB (the Flanders Institute for Biotechnology). "New insights into cancer treatment." ScienceDaily. ScienceDaily, 15 March 2011. <www.sciencedaily.com/releases/2011/03/110315103749.htm>.
VIB (the Flanders Institute for Biotechnology). (2011, March 15). New insights into cancer treatment. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2011/03/110315103749.htm
VIB (the Flanders Institute for Biotechnology). "New insights into cancer treatment." ScienceDaily. www.sciencedaily.com/releases/2011/03/110315103749.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins